Can cervical adenocarcinoma in situ be safely managed by conization alone?

Ovarian carcinoma diagnosis.

Cancer·2000

Port-site recurrence after laparoscopic surgery for endometrial carcinoma.

Obstetrics and gynecology·2000

"Curbside" consultations in gynecologic oncology: a closer look at a common practice.

Gynecologic oncology·1999

Impact of surgical staging in women with locally advanced cervical cancer.

Gynecologic oncology·1999

Adenocarcinoma of the uterine cervix metastatic to lymph nodes.

American journal of obstetrics and gynecology·1998

Oncogene expression: long-term compared with short-term survival in patients with advanced epithelial ovarian cancer.

Obstetrics and gynecology·1998

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Gynecologic oncology·2026

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Gynecologic oncology·2026

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Gynecologic oncology·2026

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Gynecologic oncology·2026

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Gynecologic oncology·2026

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Gynecologic oncology·2026

Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer-Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Association between ineffective health self-management and severe radiodermatitis: Cohort study.

International journal of nursing knowledge·2026

Systematic review: Stereotactic Body Radiation Therapy for Pancreatic Cancer: Evaluating its Efficacy, Safety, and Future Prospects.

The British journal of radiology·2026

A prospective, randomized study comparing different therapeutic modalities for acute adenoviral conjunctivitis.

Indian journal of ophthalmology·2026

Laser and Light-Based Therapies in Inflammatory Dermatoses: A Systematic Review of Safety, Efficacy, and Adverse Effects to Inform Cosmetic Use.

Lasers in surgery and medicine·2026

Related Experiment Videos

Can cervical adenocarcinoma in situ be safely managed by conization alone?

Related Concept Videos

Ovarian carcinoma diagnosis.

Port-site recurrence after laparoscopic surgery for endometrial carcinoma.

"Curbside" consultations in gynecologic oncology: a closer look at a common practice.

Impact of surgical staging in women with locally advanced cervical cancer.

Adenocarcinoma of the uterine cervix metastatic to lymph nodes.

Oncogene expression: long-term compared with short-term survival in patients with advanced epithelial ovarian cancer.

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer-Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy.

Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.

Association between ineffective health self-management and severe radiodermatitis: Cohort study.

Systematic review: Stereotactic Body Radiation Therapy for Pancreatic Cancer: Evaluating its Efficacy, Safety, and Future Prospects.

A prospective, randomized study comparing different therapeutic modalities for acute adenoviral conjunctivitis.

Laser and Light-Based Therapies in Inflammatory Dermatoses: A Systematic Review of Safety, Efficacy, and Adverse Effects to Inform Cosmetic Use.

Related Experiment Videos

Can cervical adenocarcinoma in situ be safely managed by conization alone?

Related Concept Videos

Related Articles